Skip to main content

Abstract

The prostatic urethral lift (PUL) is a minimally invasive device for the treatment of lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH). It recently received Food and Drug Administration (FDA) approval as a treatment for LUTS in September 2013. PUL is mechanically based and does not involve the destruction or physical removal of prostatic tissue. It differs from other mechanically based treatments such as prostatic urethral stents because it does not attempt to conform to the anatomy of the prostatic urethra. Furthermore, the prosthesis becomes incorporated into the prostate and is covered by the urothelium. PUL is performed under endoscopic guidance and prostheses are deployed with the aim of retracting the prostatic urethra towards the prostate capsule to open the prostatic urethral space. In this chapter, we discuss the indication, current studies, and role of PUL in the management of LUTs secondary to BPH.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Barkin J, Giddens J, Incze P, Casey R, Richardson S, Gange S. UroLift system for relief of prostate obstruction under local anesthesia. Can J Urol. 2012;19:6217–22.

    PubMed  Google Scholar 

  2. McNicholas TA, Woo HH, Chin PT, et al. Minimally invasive prostatic urethral lift: surgical technique and multinational experience. Eur Urol. 2013;64:292–9.

    Article  PubMed  Google Scholar 

  3. Woo HH, Chin PT, McNicholas TA, et al. Safety and feasibility of the prostatic urethral lift: a novel, minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). BJU Int. 2011;108:82–8.

    Article  PubMed  Google Scholar 

  4. Chin PT, Bolton DM, Jack G, et al. Prostatic urethral lift: two-year results after treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urology. 2012;79:5–11.

    Article  PubMed  Google Scholar 

  5. Roehrborn CG, Gange SN, Shore ND, et al. The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study. J Urol. 2013;190:2161–7.

    Article  PubMed  Google Scholar 

  6. Cantwell AL, Bogache WK, Richardson SF, Tutrone RF, Barkin J, Fagelson JE, Chin PT, Woo HH. Multicentre prospective crossover study of the ‘prostatic urethral lift’ for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. BJU Int. 2014;113:615–22.

    Article  PubMed  Google Scholar 

  7. Delongchamps NB, Conquy S, Defontaines J, Zerbib M, Peyromaure M. Intra-prostatic UroLift((R)) implants for benign prostatic hyperplasia: preliminary results of the four first cases performed in France. Progres en urologie: journal de l’Association francaise d’urologie et de la Societe francaise d’urologie. 2012;22:590–7.

    Article  CAS  Google Scholar 

  8. Garrido Abad P, Coloma Del Peso A, Sinues Ojas B, Fernandez Arjona M. Urolift(R), a new minimally invasive treatment for patients with low urinary tract symptoms secondary to BPH. Preliminary results. Arch Esp Urol. 2013;66:584–91.

    PubMed  Google Scholar 

  9. Woo HH, Bolton DM, Laborde E, et al. Preservation of sexual function with the prostatic urethral lift: a novel treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Sex Med. 2012;9:568–75.

    Article  PubMed  Google Scholar 

  10. McVary KT, Gange SN, Shore ND, et al. Treatment of LUTS secondary to BPH while preserving sexual function: randomized controlled study of prostatic urethral lift. J Sex Med. 2014;11(1):279–87. doi:10.1111/jsm.12333. Epub 2013 Sep 30. PMID: 24119101 [PubMed – in process].

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Henry H. Woo M.B.B.S., FRACS (Urol) .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Woo, H.H. (2015). Prostatic Tissue Approximation (Urolift). In: Chughtai, B., Te, A., Kaplan, S. (eds) Treatment of Benign Prostatic Hyperplasia: Modern Alternative to Transurethral Resection of the Prostate. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1587-3_18

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-1587-3_18

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-1586-6

  • Online ISBN: 978-1-4939-1587-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics